CD79A and infection: In addition, individuals with high levels of IgA against the SARS-CoV-2 ancestral strain spike antigen in the nasal mucosa show decreased risk of Omicron-breakthrough infection (23), indicating that IgA in the nasal mucosa has a highly cross-protective effect against infection with SARS-CoV-2 variants.